2,5-Dimethoxy-4-methylamphetamine

From WikiMD's WELLNESSPEDIA

2,5-Dimethoxy-4-methylamphetamine[edit]

Chemical structure of 2,5-Dimethoxy-4-methylamphetamine

2,5-Dimethoxy-4-methylamphetamine (DOM) is a psychedelic drug and a substituted amphetamine. It is known for its potent hallucinogenic effects and is a member of the phenethylamine class of compounds.

Chemical Structure and Properties[edit]

2,5-Dimethoxy-4-methylamphetamine is a substituted amphetamine with the chemical formula C12H19NO2. It features a methoxy group at the 2 and 5 positions and a methyl group at the 4 position of the phenyl ring. The presence of these groups contributes to its psychoactive properties.

Pharmacology[edit]

DOM acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor. This interaction is responsible for its psychedelic effects, which include altered perception, mood, and cognition. The drug is known for its long duration of action, often lasting 14 to 20 hours.

History and Usage[edit]

DOM was first synthesized by Alexander Shulgin in the 1960s. It gained popularity in the 1960s and 1970s as a recreational drug. Shulgin documented its synthesis and effects in his book PiHKAL: A Chemical Love Story.

Effects[edit]

The effects of DOM are similar to those of other psychedelics such as LSD and mescaline. Users report visual hallucinations, altered sense of time, and changes in mood and thought patterns. Due to its potency, the effects can be overwhelming, and it is considered a "heavy" psychedelic.

Legal Status[edit]

DOM is classified as a Schedule I controlled substance in the United States, meaning it is illegal to manufacture, buy, possess, or distribute without a DEA license. It is similarly controlled in many other countries.

Related Compounds[edit]

DOM is part of a family of compounds known as the 2C family, which includes other psychedelics such as 2C-B, 2C-I, and 2C-E. These compounds share a similar chemical structure and mechanism of action.

See Also[edit]

Gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.